Outcomes After Combined Modality Therapy for EGFR-Mutant and Wild-Type Locally Advanced NSCLC

BACKGROUND. Epidermal growth factor receptor (EGFR) mutations identify a unique biological subtype of non-small cell lung cancer (NSCLC). Treatment outcomes for EGFR-mutant locally advanced NSCLC patients have not been well described. METHODS. We retrospectively examined outcomes after combined moda...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Mak, Raymond H., Doran, Elizabeth, Muzikansky, Alona, Kang, Josephine, Neal, Joel W., Baldini, Elizabeth H., Choi, Noah C., Willers, Henning, Jackman, David M., Sequist, Lecia V.
Formato: Artigo
Idioma:Inglês
Publicado: AlphaMed Press 2011
Assuntos:
Lung Cancer
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3228219/
https://ncbi.nlm.nih.gov/pubmed/21632451
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0040
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares